PRMT5 and neoplasm: Similarly, hnRNPA1 is methylated by PRMT3, PRMT4, PRMT5, and PRMT7, with methylation affecting alternative splicing patterns relevant to tumor progression and therapy resistance (Fig. 3A) [153, 154].